| Financial Year |
March 31 2023 |
| Monetary Funds |
1,279,485,272.28 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,703,616.38 |
| Accounts Receivable |
210,152,375.22 |
| Advances to Suppliers |
164,422,050.23 |
| Other Receivables |
30,385,739.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
199,325,841.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
96,719,340.14 |
| Total Current Assets |
2,308,664,965.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,412,680.57 |
| Investment Properties |
-- |
| Fixed Assetes |
404,921,062.37 |
| Under-construction Projects |
52,382,864.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
105,772,289.14 |
| R&D expenses |
-- |
| Goodwill |
19,254,870.65 |
| Long-Term Deferred and Prepaid Expenses |
118,753.43 |
| Deferred Income Tax Assets |
21,388,139.76 |
| Other Non-Current Assets |
14,888,227.41 |
| Sub-Total of Non-Current Assets |
967,615,790.16 |
| Total Assets |
3,276,280,755.92 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,180,122.55 |
| Accounts Payable |
239,396,957.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,257,167.39 |
| Taxes Payable |
18,252,100.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,324,222.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,045,960.42 |
| Other Current Liabilities |
8,867,064.69 |
| Sub-Total of Current Liabilities |
397,676,042.46 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
813,379.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,353,454.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
115,262,611.92 |
| Total Liabilities |
512,938,654.38 |
| Paid-In Capital(Or Share Stock) |
648,862,630.00 |
| Capital Surplus |
645,724,240.39 |
| Surplus Reserve |
133,223,478.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,200,270,874.60 |
| Minority Stockholder's Interest |
121,609,990.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,641,732,111.03 |
| Owner's Equity（Stockholder's Equity） |
2,763,342,101.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,276,280,755.92 |
